Biofarm Sp. z o. o. (Ltd.) is one of the leading Polish pharmaceutical manufacturers. The company was established in 1988. In 2001 Biofarm was one of the first Polish companies granted with the GMP certificate confirming their compliance with the highest quality standards for pharmaceutical production. This, together with constant development of their facility with state-of-the-art technology makes them a reliable partner.
With a global turnover of 110 million USD in 2013, Biofarm was ranked 19th among over 500 pharmaceutical companies from all over the world in the Polish market, and 3rd pharmaceutical manufacturer with solely Polish capital, which makes them a serious player in the domestic field. Their company’s competitive advantage is built mainly on a highly qualified staff and an excellent product portfolio, which currently includes over 80 medicinal products and numerous dietary supplements in the fields of cardiology, neurology, oncology, psychiatry, gastrology and general practice. Biofarm exports its production to over 10 countries all over the world.
Biofarm Sp. z o. o.
Tel. +48 61 665 16 29
13 Wałbrzyska St.
60-198 Poznań, Poland
e-mail: biofarm@biofarm.pl
“Average pharmaceutical company expenditures on R&D are in the range of 13 to 15 percent of revenues: much higher than the global average, and much higher than other Polish industrial…
With a geostrategic location and easy access to both Western Europe and the rest of the emerging Central and Eastern Europe (CEE) region, Poland represents the sixth largest pharma market…
Poland’s largest pharmaceutical company and leading generics manufacturer, Polpharma, is looking to expand its presence outside of the country’s borders. With a recent acquisition bid for former Sanofi European generics…
Some of the most important stories emanating from the Central and Eastern European (CEE) region’s pharma industry, including Polpharma’s bid for Zentiva, Richter’s acquisition of OC Distributors and MDD approval…
Some of the top stories emanating from Poland’s pharma industry, including Polish biotech Ryvu Therapeutics’ exclusive deal with Exelixis, the partnership between Polpharma and startup Pikralida on a promising epilepsy…
Some of the most important stories emanating from the Central and Eastern European (CEE) region’s pharma industry, including Poland’s most promising biotech start-ups, an interview with Zentiva CEO Nick Haggar,…
Every year, Polish news magazine Wprost publishes its ranking of the top 200 Polish companies across all industries. Here, we profile the top five pharma-related companies featured in the 2019 rankings.…
Reinier Schlatmann, Philips CEO in Central and Eastern Europe, talks about the strategic significance of Poland for the company and how the implementation of Philips’ strategy and its focus on…
Ewa Sek, general manager at ResMed Poland, explains the crucial role of ResMed in raising awareness on sleep apnea, COPD and other respiratory-related conditions in Poland and highlights the important…
Jan Kruk of Polish pharmaceutical logistics and distribution specialist, Cefarm, discusses the organization’s secrets of success, as well as the broader logistics and distribution landscape in Poland. As the president…
Arjo, formerly Arjo Huntleigh, has undergone a rebrand and established its first formal office in Poland in 2017. Konrad Pianko, president of the CEE region which includes over 22 countries,…
Dariusz Adamusiński, general manager of A&D Pharma’s Polish operations has a busy year ahead. A new warehouse in Poland, partnerships across the pharmaceutical spectrum coupled with new regulations are all…
As east area director for the vast CEE market, Pawel Mazur explains how Accord Healthcare has gone from strength to strength in Poland, with the intention of becoming a top…
See our Cookie Privacy Policy Here